Consensus guidelines on anti-cardiolipin antibody testing and reporting

By Wong Richard   Gillis David   Adelstein Stephen   Baumgart Karl   Favaloro Emmanuel   Hendle Michelle   Homes Paul   Pollock Wendy   Smith Stewart   Steele Richard   Sturgess Allan   Wilson Robert  

Pathology, Vol. 36, Iss. 1, 2004-02 ,pp. : 63-68

Ashgate Publishing Ltd

Access to resources Recommend Favorite

CLINICAL UTILITY OF ANTICARDIOLIPIN ANTIBODY ASSAYS: HIGH INTER-LABORATORY VARIATION AND LIMITED CONSENSUS BY PARTICIPANTS OF EXTERNAL QUALITY ASSURANCE PROGRAMS SIGNALS A CAUTIOUS APPROACH

By Favaloro Emmanuel J.   Silvestrini Roger   Mohammed Ali  

Pathology, Vol. 31, Iss. 2, 1999-05 ,pp. : 142-147

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Anti-cardiolipin antibody testing and reporting practices among laboratories participating in a large external Quality Assurance Program

By Wong Richard   Wilson Robert   Gillis David   Pollock Wendy   Steele Richard  

Pathology, Vol. 36, Iss. 2, 2004-04 ,pp. : 174-181

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Multi-centre collaborative study for the in vitro evaluation of new macrolides dirithromycin and erythromycylamine

By Fernandes C.J.   Benn R.A.V.   Nimmo G.R.   Australian Group for Antimicrobial Resistance (AGAR) The  

Pathology, Vol. 27, Iss. 1, 1995-01 ,pp. : 74-78

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Wong RCW, Gillis D, Adelstein S, Baumgart K, Favaloro EJ, Hendle MJ, Homes P, Pollock W, Smith S, Steele RH, Sturgess A, Wilson RJ. Consensus guidelines on anti-cardiolipin antibody testing and reporting. Pathology 2004; 36: 63-8.

By  

Pathology, Vol. 36, Iss. 2, 2004-04 ,pp. : 215-215

Ashgate Publishing Ltd

Access to resources Recommend Favorite